{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:28:28Z","timestamp":1791106108994,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.nbd.2010.09.021","type":"journal-article","created":{"date-parts":[[2010,11,7]],"date-time":"2010-11-07T04:08:12Z","timestamp":1289102892000},"page":"570-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease"],"prefix":"10.1016","volume":"41","author":[{"given":"St\u00e9phane","family":"Mievis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ledent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2010.09.021_bb0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410310412","article-title":"Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease","volume":"31","author":"Albin","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2010.09.021_bb0010","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1523\/JNEUROSCI.23-34-10982.2003","article-title":"Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively","volume":"23","author":"Alfinito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.09.021_bb0015","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2004.09.017","article-title":"Minocycline in phenotypic models of Huntington's disease","volume":"18","author":"Bantubungi","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2010.09.021_bb0020","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0512","article-title":"Striatal and cortical neurochemical changes induced by chronic metabolic compromise in the 3-nitropropionic model of Huntington's disease","volume":"10","author":"Blum","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2010.09.021_bb0025","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1474-4422(03)00411-3","article-title":"Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics","volume":"2","author":"Blum","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2010.09.021_bb0030","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1523\/JNEUROSCI.23-12-05361.2003","article-title":"A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists","volume":"23","author":"Blum","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.09.021_bb0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.coph.2007.09.002","article-title":"Adenosine as a neuromodulator in neurological diseases","volume":"8","author":"Boison","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.nbd.2010.09.021_bb0040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington's disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2010.09.021_bb0045","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.09.021_bb0050","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","article-title":"Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease","volume":"354","author":"Cha","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.nbd.2010.09.021_bb0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington's disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2010.09.021_bb0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pneurobio.2007.09.002","article-title":"Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and \u201cfine tuning\u201d modulation","volume":"83","author":"Chen","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2010.09.021_bb0065","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/hmg\/ddp230","article-title":"The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system","volume":"18","author":"Chiang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2010.09.021_bb0070","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","article-title":"CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model","volume":"93","author":"Chou","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2010.09.021_bb0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.expneurol.2008.05.015","article-title":"Adenosine A2A receptor antagonism increases nNOS-immunoreactive neurons in the striatum of Huntington transgenic mice","volume":"213","author":"Cipriani","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2010.09.021_bb0080","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nbd.2009.06.009","article-title":"A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease","volume":"35","author":"Dhaenens","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2010.09.021_bb0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nbd.2007.07.009","article-title":"Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6\/2 Huntington's disease mice","volume":"28","author":"Domenici","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2010.09.021_bb0090","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","article-title":"Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease","volume":"30","author":"Duan","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2010.09.021_bb0095","series-title":"AAN meeting, Toronto","article-title":"Impact of Caffeine Intake on Huntington's Disease (HD) Course","author":"Duru","year":"2010"},{"key":"10.1016\/j.nbd.2010.09.021_bb0100","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.09.021_bb0105","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1471-4159.2003.02145.x","article-title":"Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage","volume":"88","author":"Fink","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2010.09.021_bb0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pneurobio.2007.07.005","article-title":"Aspects of the general biology of adenosine A2A signaling","volume":"83","author":"Fredholm","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2010.09.021_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2010.09.021_bb0120","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1046\/j.1471-4159.2003.01916.x","article-title":"Changes in GAD67 mRNA expression evidenced by in situ hybridization in the brain of R6\/2 transgenic mice","volume":"86","author":"Gourfinkel-An","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2010.09.021_bb0125","doi-asserted-by":"crossref","first-page":"11371","DOI":"10.1523\/JNEUROSCI.1907-06.2006","article-title":"Adenosine A2A receptors in bone marrow-derived cells but not in forebrain neurons are important contributors to 3-nitropropionic acid-induced striatal damage as revealed by cell-type-selective inactivation","volume":"26","author":"Huang","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.09.021_bb0130","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/41771","article-title":"Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor","volume":"388","author":"Ledent","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2010.09.021_bb0135","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0006-291X(05)80909-X","article-title":"RDC8 codes for an adenosine A2 receptor with physiological constitutive activity","volume":"173","author":"Maenhaut","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2010.09.021_bb0140","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2007.02.034","article-title":"Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice","volume":"417","author":"Martire","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2010.09.021_bb0145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2008.01.014","article-title":"Tiagabine is neuroprotective in the N171-82Q and R6\/2 mouse models of Huntington's disease","volume":"30","author":"Masuda","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2010.09.021_bb0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1385\/NMM:9:1:47","article-title":"Lack of minocycline efficiency in genetic models of Huntington's disease","volume":"9","author":"Mievis","year":"2007","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.nbd.2010.09.021_bb0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/nen.0b013e3180517477","article-title":"Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration","volume":"66","author":"Minghetti","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2010.09.021_bb0160","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2174\/138161208784480117","article-title":"A critical evaluation of adenosine A2A receptors as potentially \u201cdruggable\u201d targets in Huntington's disease","volume":"14","author":"Popoli","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2010.09.021_bb0165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pneurobio.2006.12.005","article-title":"Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease","volume":"81","author":"Popoli","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2010.09.021_bb0170","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1523\/JNEUROSCI.22-05-01967.2002","article-title":"Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum","volume":"22","author":"Popoli","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.09.021_bb0175","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2010.09.021_bb0180","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2010.09.021_bb0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneumeth.2004.03.026","article-title":"Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression","volume":"140","author":"Szapacs","year":"2004","journal-title":"J. Neurosci. Meth."},{"key":"10.1016\/j.nbd.2010.09.021_bb0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2006.01.014","article-title":"Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease","volume":"23","author":"Tarditi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2010.09.021_bb0195","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2010.09.021_bb0200","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2010.09.021_bb0205","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996110003724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996110003724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:08:35Z","timestamp":1760850515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996110003724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0969996110003724"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2010.09.021","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2010.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}